» Articles » PMID: 37927468

Lipid Metabolism Reprogramming in Head and Neck Cancer

Overview
Journal Front Oncol
Specialty Oncology
Date 2023 Nov 6
PMID 37927468
Authors
Affiliations
Soon will be listed here.
Abstract

Lipid metabolism reprogramming is one of the most prominent metabolic anomalies in cancer, wherein cancer cells undergo dysregulation of lipid metabolism to acquire adequate energy, cell membrane building blocks, as well as signaling molecules essential for cell proliferation, survival, invasion, and metastasis. These adaptations enable cancer cells to effectively respond to challenges posed by the tumor microenvironment, leading to cancer therapy resistance and poor cancer prognosis. Head and neck cancer, ranking as the seventh most prevalent cancer, exhibits numerous abnormalities in lipid metabolism. Nevertheless, the precise role of lipid metabolic rewiring in head and neck cancer remains unclear. In line with the LIPID MAPS Lipid Classification System and cancer risk factors, the present review delves into the dysregulated molecules and pathways participating in the process of lipid uptake, biosynthesis, transportation, and catabolism. We also present an overview of the latest advancements in understanding alterations in lipid metabolism and how they intersect with the carcinogenesis, development, treatment, and prognosis of head and neck cancer. By shedding light on the significance of metabolic therapy, we aspire to improve the overall prognosis and treatment outcomes of head and neck cancer patients.

Citing Articles

The role of lipids and lipids lowering drugs in human papillomavirus (HPV) and HPV-associated cancers.

Shabani E, Hasanzadi A, Allela O, Kareem R, Abed R, Ali Al-Nuaimi A Infect Agent Cancer. 2025; 20(1):4.

PMID: 39876011 PMC: 11773819. DOI: 10.1186/s13027-025-00635-5.

References
1.
Gronhoj C, Jakobsen K, Jensen D, Rasmussen J, Andersen E, Friborg J . Pattern of and survival following loco-regional and distant recurrence in patients with HPV+ and HPV- oropharyngeal squamous cell carcinoma: A population-based study. Oral Oncol. 2018; 83:127-133. DOI: 10.1016/j.oraloncology.2018.06.012. View

2.
Zhou X, Wei J, Chen F, Xiao X, Huang T, He Q . Epigenetic downregulation of the ISG15-conjugating enzyme UbcH8 impairs lipolysis and correlates with poor prognosis in nasopharyngeal carcinoma. Oncotarget. 2015; 6(38):41077-91. PMC: 4747391. DOI: 10.18632/oncotarget.6218. View

3.
Li K, Chen L, Lin Z, Zhu J, Fang Y, Du J . Role of the AMPK/ACC Signaling Pathway in TRPP2-Mediated Head and Neck Cancer Cell Proliferation. Biomed Res Int. 2020; 2020:4375075. PMC: 7683127. DOI: 10.1155/2020/4375075. View

4.
Sinha U, Schorn V, Hochstim C, Chinn S, Zhu S, Masood R . Increased radiation sensitivity of head and neck squamous cell carcinoma with sphingosine kinase 1 inhibition. Head Neck. 2010; 33(2):178-88. DOI: 10.1002/hed.21418. View

5.
Silva S, Agostini M, Nishimoto I, Coletta R, Alves F, Lopes M . Expression of fatty acid synthase, ErbB2 and Ki-67 in head and neck squamous cell carcinoma. A clinicopathological study. Oral Oncol. 2004; 40(7):688-96. DOI: 10.1016/j.oraloncology.2004.01.004. View